ALDX

Aldeyra Therapeutics Inc

• Benzinga·3d ago

  12 Health Care Stocks Moving In Tuesday's After-Market Session

• Benzinga·4d ago

  12 Health Care Stocks Moving In Monday's Intraday Session

• TipRanks·09/30 10:25

  Aldeyra Therapeutics: Neutral Rating Maintained Amid FDA Uncertainty; $2 Price Target Reaffirmed

• Dow Jones·09/30 10:24

  Aldeyra Therapeutics Price Target Maintained With a $2.00/Share by HC Wainwright & Co.

• Benzinga·09/30 10:14

  HC Wainwright & Co. Reiterates Neutral on Aldeyra Therapeutics, Maintains $2 Price Target

• Benzinga·09/29 18:34

  Aldeyra Fights Back Against FDA Rejection, Dispute Plan Triggers Rally

• Dow Jones·09/29 16:40

  Aldeyra Therapeutics Price Target Maintained With a $9.00/Share by BTIG

• Benzinga·09/29 16:30

  BTIG Reiterates Buy on Aldeyra Therapeutics, Maintains $9 Price Target

• TipRanks·09/29 11:30

  Aldeyra Pursues FDA Dispute Over Dry Eye Drug

• Seeking Alpha·09/29 11:13

  Aldeyra Therapeutics to appeal FDA rejection of dry eye disease drug reproxalap

• TipRanks·09/29 11:10

  Aldeyra to submit Formal Dispute Resolution Request to FDA for reproxalap

• TipRanks·09/29 11:10

  Aldeyra sees operational cash runway into 2029

• TipRanks·09/21 17:55

  Aldeyra Therapeutics (ALDX) Receives a Hold from H.C. Wainwright

• NASDAQ·09/17 16:13

  Kiniksa Pharmaceuticals Stock Rallies 41% in Three Months: Here's Why

• NASDAQ·09/14 15:14

  GSK Presents Jideytro Data for Potential Use in First-Line NSCLC